Abrdn PLC Cytokinetics Inc Transaction History

Abrdn PLC

$51.7 Billion
Q4 2024

A detailed history of Abrdn PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Abrdn PLC holds 450,513 shares of CYTK stock, worth $21.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

450,513

Previous 348,056 29.44%

Holding current value

$21.7 Million

Previous $18.4 Million 15.32%

% of portfolio

0.04%

Previous 0.03%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$46.36 - $58.62 $4.75 Million - $6.01 Million	102,457 Added 29.44%	450,513 $21.2 Million
Q3 2024 Oct 24, 2024	SELL	$51.22 - $60.16 $1.08 Million - $1.27 Million	-21,181 Reduced 5.74%	348,056 $18.4 Million
Q2 2024 Aug 09, 2024	BUY	$47.86 - $75.05 $6.22 Million - $9.76 Million	129,995 Added 54.34%	369,237 $20 Million
Q1 2024 May 08, 2024	BUY	$63.75 - $108.06 $6.95 Million - $11.8 Million	108,982 Added 83.66%	239,242 $16.8 Million
Q4 2023 Jan 31, 2024	BUY	$26.88 - $83.49 $3.5 Million - $10.9 Million	130,260 New	130,260 $10.9 Million

Others Institutions Holding CYTK

# of Institutions

396

Shares Held

122M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.53B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account